EDWARDS LIFESCIENCES CORPORATION financials

  1. Home
  2. Financials
  3. EW
EW CIK 0001099800

Source: EDGAR filings · Built 2026-06-02T02:57:28Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.33B 289.90M 642.80M 973.60M 1.41B 647.30M
EBITDA 1.42B 1.53B 1.45B 1.64B 1.83B 1.00B
Working Capital 4.93B 4.78B 2.84B 2.07B 2.15B 2.20B
Net Debt -2.23B -2.35B -447.20M -77.70M -172.50M -488.30M
Gross Margin 78.01% 79.46% 80.47% 83.79% 76.13% 75.36%
Operating Margin 20.84% 25.35% 26.13% 33.57% 32.30% 20.46%
Net Margin 17.69% 76.75% 27.99% 34.09% 28.73% 18.77%
Return on Equity (ROE) 10.38% 41.75% 21.09% 26.21% 25.76% 18.00%
Return on Assets (ROA) 7.84% 31.98% 14.98% 18.35% 17.68% 11.38%
Current Ratio 3.72× 4.18× 3.38× 3.03× 3.08× 3.46×
Debt-to-Equity 0.07× 0.07× 0.10× 0.12× 0.12× 0.15×
Effective Tax Rate 17.04% 9.82% 11.10% 12.87% 11.69% 10.18%
Cash Conversion Ratio 1.49× 0.13× 0.64× 0.80× 1.15× 1.28×
Accruals Ratio -0.04× 0.28× 0.05× 0.04× -0.03× -0.03×
SBC % of Revenue 2.61% 2.98% 2.78% 2.84% 2.09% 2.11%
CapEx Coverage 6.13× 2.15× 3.54× 4.98× 5.32× 2.59×
Free Cash Flow Per Share $2.28 $0.48 $1.05 $1.56 $2.23 $1.02

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 46.58× 10.62× 33.15× 30.58× 54.43× 70.18×
P/FCF 37.41× 153.05× 72.29× 47.83× 58.15× 89.06×
FCF Yield 2.67% 0.65% 1.38% 2.09% 1.72% 1.12%
EV / EBITDA 33.27× 26.88× 31.22× 27.66× 44.21× 56.20×
P/S 8.16× 8.01× 9.15× 10.17× 15.45× 12.98×
P/B 4.79× 4.36× 6.89× 7.82× 13.85× 12.45×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 6.07B 5.44B 5.01B 4.46B 5.23B 4.39B
Cost of Goods and Services Sold 1.33B 1.12B 978.40M 723.70M 1.25B 1.08B
Gross Profit 4.73B 4.32B 4.03B 3.74B 3.98B 3.31B
Research and Development Expense 1.08B 1.05B 962.90M 843.60M 903.10M 760.70M
Selling, General and Administrative Expense 2.09B 1.79B 1.58B 1.36B 1.49B 1.23B
Operating Income (Loss) 1.26B 1.38B 1.31B 1.50B 1.69B 897.60M
Income Tax Expense (Benefit) 216.90M 152.10M 152.40M 195.50M 198.90M 93.30M
Net Income (Loss) Attributable to Parent 1.07B 4.17B 1.40B 1.52B 1.50B —
Earnings Per Share, Basic $1.84 $6.98 $2.31 $2.46 $2.41 $1.32
Weighted Average Number of Shares Outstanding, Basic 584.80M 597.70M 606.70M 619.00M 623.30M 622.60M
Earnings Per Share, Diluted $1.83 $6.97 $2.30 $2.44 $2.38 $1.30
Weighted Average Number of Shares Outstanding, Diluted 585.80M 599.30M 609.40M 624.20M 631.20M 631.90M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.94B 3.05B 1.13B 769.00M 862.80M 1.18B
Assets, Current 6.74B 6.29B 4.04B 3.10B 3.18B 3.09B
Assets 13.70B 13.06B 9.36B 8.29B 8.50B 7.24B
Liabilities, Current 1.81B 1.51B 1.20B 1.02B 1.03B 893.90M
Long-term Debt, Excluding Current Maturities 598.30M 597.70M 597.00M 596.30M 595.70M 595.00M
Liabilities 3.36B 2.99B 2.64B 2.49B 2.67B 2.66B
Stockholders' Equity Attributable to Parent 10.34B 10.00B 6.65B 5.81B 5.84B 4.57B
Common Stock, Shares, Outstanding 580.70M 588.60M 601.10M 608.30M 624.10M 624.30M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.60B 542.30M 895.80M 1.22B 1.73B 1.05B
Payments to Acquire Property, Plant, and Equipment 260.20M 252.40M 253.00M 244.60M 325.80M 407.00M
Net Cash Provided by (Used in) Investing Activities -712.90M 2.31B 173.80M 252.30M -1.72B -531.10M
Payments for Repurchase of Common Stock 893.40M 1.16B 879.60M 1.73B 512.80M 625.40M
Net Cash Provided by (Used in) Financing Activities -956.80M -983.00M -711.00M -1.58B -356.30M -486.90M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EW CIK 0001099800), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

OSW

OneSpaWorld Holdings Limited

ACCS

ACCESS Newswire Inc.

FET

FORUM ENERGY TECHNOLOGIES, INC.